Quick Answer
Nurix Therapeutics, Inc. reported Total Assets of $688.13 million for fiscal year 2025.
Nurix Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $688.13M | +2.8% |
| 2024 | $669.34M | +88.2% |
| 2023 | $355.60M | -14.7% |
| 2022 | $416.76M | -12.6% |
| 2021 | $476.77M | +20.3% |
| 2020 | $396.34M | +799.8% |
| 2019 | $44.05M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| August 31, 2025 | $522.47M | +1.7% | -11.7% |
| May 31, 2025 | $591.55M | +15.8% | -3.8% |
| February 28, 2025 | $615.04M | +96.7% | -8.1% |
| November 30, 2024 | $669.34M | +88.2% | +30.3% |
| August 31, 2024 | $513.60M | +66.6% | +0.5% |
| May 31, 2024 | $511.03M | +45.7% | +63.4% |
| February 29, 2024 | $312.67M | -15.5% | -12.1% |
| November 30, 2023 | $355.60M | -14.7% | +15.4% |
- Nurix Therapeutics, Inc. showed an increase of +2.8% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Nurix Therapeutics, Inc.’s total assets has grown by 1462.2% (from $44.05 million to $688.13 million).
- The most recent figure is from Nurix Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 28, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: